Financhill
Sell
38

BZH Quote, Financials, Valuation and Earnings

Last price:
$27.84
Seasonality move :
-2.93%
Day range:
$27.56 - $28.43
52-week range:
$25.48 - $38.22
Dividend yield:
0%
P/E ratio:
6.16x
P/S ratio:
0.37x
P/B ratio:
0.70x
Volume:
565.2K
Avg. volume:
352.6K
1-year change:
-15.45%
Market cap:
$866.9M
Revenue:
$2.3B
EPS (TTM):
$4.53
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.1B $2.1B $2.3B $2.2B $2.3B
Revenue Growth (YoY) 1.88% 0.62% 8.26% -4.76% 5.59%
 
Cost of Revenues $1.8B $1.7B $1.8B $1.8B $1.9B
Gross Profit $347.6M $404.3M $537.5M $442.7M $424.3M
Gross Profit Margin 16.34% 18.89% 23.2% 20.06% 18.21%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $170.4M $163.3M $177.3M $179.8M $186.3M
Other Inc / (Exp) -$7.8M -$3.1M $1.5M $5.4M $16.1M
Operating Expenses $268.5M $257.4M $265M $265.4M $281.3M
Operating Income $79.1M $146.9M $272.5M $177.3M $143M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $71.3M $143.7M $274M $182.6M $159.1M
Earnings of Discontinued Ops. -$1.1M -$159K -$14K -$77K --
Income Tax Expense $18M $21.5M $53.3M $24M $18.9M
Net Income to Company $52.2M $122M $220.7M $158.6M $140.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $52.2M $122M $220.7M $158.6M $140.2M
 
Basic EPS (Cont. Ops) $1.76 $4.07 $7.25 $5.23 $4.59
Diluted EPS (Cont. Ops) $1.74 $4.01 $7.17 $5.16 $4.53
Weighted Average Basic Share $29.7M $30M $30.4M $30.4M $30.5M
Weighted Average Diluted Share $29.9M $30.4M $30.8M $30.7M $31M
 
EBITDA $94.7M $160.8M $285.9M $189.5M $157.9M
EBIT $79.1M $146.9M $272.5M $177.3M $143M
 
Revenue (Reported) $2.1B $2.1B $2.3B $2.2B $2.3B
Operating Income (Reported) $79.1M $146.9M $272.5M $177.3M $143M
Operating Income (Adjusted) $79.1M $146.9M $272.5M $177.3M $143M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $686.7M $590.9M $827.7M $645.4M $806.2M
Revenue Growth (YoY) -12.15% -13.95% 40.06% -22.02% 24.91%
 
Cost of Revenues $570.1M $475.4M $639.8M $508.1M $664.8M
Gross Profit $116.6M $115.5M $187.9M $137.3M $141.4M
Gross Profit Margin 16.98% 19.55% 22.7% 21.27% 17.54%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $49.4M $43.4M $48.3M $49.9M $50.7M
Other Inc / (Exp) -$1.9M $402K $717K $2.2M $2.4M
Operating Expenses $81M $68.6M $78.2M $75.2M $83.2M
Operating Income $35.6M $46.9M $109.7M $62.1M $58.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $33.7M $47.3M $110.4M $64.2M $60.6M
Earnings of Discontinued Ops. -$949K $2K -$10K -- -$2K
Income Tax Expense $9M -$1.1M $23.6M $8.5M $8.5M
Net Income to Company $23.7M $48.4M $86.8M $55.8M $52.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $23.7M $48.4M $86.8M $55.8M $52.1M
 
Basic EPS (Cont. Ops) $0.80 $1.61 $2.87 $1.83 $1.71
Diluted EPS (Cont. Ops) $0.79 $1.57 $2.82 $1.80 $1.69
Weighted Average Basic Share $29.6M $30.1M $30.3M $30.4M $30.3M
Weighted Average Diluted Share $29.8M $30.9M $30.8M $31M $30.8M
 
EBITDA $40.4M $50.4M $114M $65.8M $63.4M
EBIT $35.6M $46.9M $109.7M $62.1M $58.2M
 
Revenue (Reported) $686.7M $590.9M $827.7M $645.4M $806.2M
Operating Income (Reported) $35.6M $46.9M $109.7M $62.1M $58.2M
Operating Income (Adjusted) $35.6M $46.9M $109.7M $62.1M $58.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.1B $2.1B $2.3B $2.2B $2.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.8B $1.7B $1.8B $1.8B $1.9B
Gross Profit $347.6M $404.3M $537.5M $442.7M $424.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $170.4M $163.3M $177.3M $179.8M $186.3M
Other Inc / (Exp) -$7.8M -$3.1M $1.5M $5.4M $16.1M
Operating Expenses $268.5M $257.4M $265M $265.4M $281.3M
Operating Income $79.1M $146.9M $272.5M $177.3M $143M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $71.3M $143.7M $274M $182.6M $159.1M
Earnings of Discontinued Ops. -$1.1M -$159K -$14K -$77K --
Income Tax Expense $18M $21.5M $53.3M $24M $18.9M
Net Income to Company $52.2M $122M $220.7M $158.6M $140.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $52.2M $122M $220.7M $158.6M $140.2M
 
Basic EPS (Cont. Ops) $1.76 $4.07 $7.26 $5.22 $4.58
Diluted EPS (Cont. Ops) $1.74 $4.00 $7.17 $5.15 $4.53
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $94.7M $160.8M $285.9M $189.5M $157.9M
EBIT $79.1M $146.9M $272.5M $177.3M $143M
 
Revenue (Reported) $2.1B $2.1B $2.3B $2.2B $2.3B
Operating Income (Reported) $79.1M $146.9M $272.5M $177.3M $143M
Operating Income (Adjusted) $79.1M $146.9M $272.5M $177.3M $143M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $2.1B $2.3B $2.2B $2.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.7B $1.8B $1.8B $1.9B --
Gross Profit $404.3M $537.5M $442.7M $424.3M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $163.3M $177.3M $179.8M $186.3M --
Other Inc / (Exp) -$3.1M $1.5M $5.4M $16.1M --
Operating Expenses $257.4M $265M $265.4M $281.3M --
Operating Income $146.9M $272.5M $177.3M $143M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $143.7M $274M $182.6M $159.1M --
Earnings of Discontinued Ops. -$159K -$14K -$77K -- --
Income Tax Expense $21.5M $53.3M $24M $18.9M --
Net Income to Company $122M $220.7M $158.6M $140.2M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $122M $220.7M $158.6M $140.2M --
 
Basic EPS (Cont. Ops) $4.07 $7.26 $5.22 $4.58 --
Diluted EPS (Cont. Ops) $4.00 $7.17 $5.15 $4.53 --
Weighted Average Basic Share $119.8M $121.7M $121.4M $122.2M --
Weighted Average Diluted Share $121.7M $123.2M $123M $123.8M --
 
EBITDA $160.8M $285.9M $189.5M $157.9M --
EBIT $146.9M $272.5M $177.3M $143M --
 
Revenue (Reported) $2.1B $2.3B $2.2B $2.3B --
Operating Income (Reported) $146.9M $272.5M $177.3M $143M --
Operating Income (Adjusted) $146.9M $272.5M $177.3M $143M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $327.7M $246.7M $214.6M $345.6M $203.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $19.8M $25.7M $35.9M $45.6M $65.4M
Inventory $1.4B $1.5B $1.7B $1.8B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $1.7B $1.8B $2B $2.2B $2.3B
 
Property Plant And Equipment $35.4M $35.2M $34.4M $48.5M $57M
Long-Term Investments $4M $4.5M -- -- --
Goodwill $11.4M $11.4M $11.4M $11.4M $11.4M
Other Intangibles -- -- -- -- --
Other Long-Term Assets $9.2M $11.6M $14.7M $29.1M $46M
Total Assets $2B $2.1B $2.3B $2.4B $2.6B
 
Accounts Payable $132.2M $133.4M $143.6M $154.3M $164.4M
Accrued Expenses $41.9M $44.1M $32.6M $32.5M $32.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $193.6M $206M $210.8M $227.7M $230.8M
 
Long-Term Debt $1.1B $1.1B $983.4M $978M $1B
Capital Leases -- -- -- -- --
Total Liabilities $1.4B $1.4B $1.3B $1.3B $1.4B
 
Common Stock $31K $31K $31K $31K $31K
Other Common Equity Adj -- -- -- -- --
Common Equity $593.2M $724.9M $939.3M $1.1B $1.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $593.2M $724.9M $939.3M $1.1B $1.2B
 
Total Liabilities and Equity $2B $2.1B $2.3B $2.4B $2.6B
Cash and Short Terms $327.7M $246.7M $214.6M $345.6M $203.9M
Total Debt $1.1B $1.1B $983.4M $978M $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $327.7M $246.7M $214.6M $345.6M $203.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $19.8M $25.7M $35.9M $45.6M $65.4M
Inventory $1.4B $1.5B $1.7B $1.8B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $1.7B $1.8B $2B $2.2B $2.3B
 
Property Plant And Equipment $35.4M $35.2M $34.4M $48.5M $57M
Long-Term Investments $4M $4.5M -- -- --
Goodwill $11.4M $11.4M $11.4M $11.4M $11.4M
Other Intangibles -- -- -- -- --
Other Long-Term Assets $9.2M $11.6M $14.7M $29.1M $46M
Total Assets $2B $2.1B $2.3B $2.4B $2.6B
 
Accounts Payable $132.2M $133.4M $143.6M $154.3M $164.4M
Accrued Expenses $41.9M $44.1M $32.6M $32.5M $32.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $193.6M $206M $210.8M $227.7M $230.8M
 
Long-Term Debt $1.1B $1.1B $983.4M $978M $1B
Capital Leases -- -- -- -- --
Total Liabilities $1.4B $1.4B $1.3B $1.3B $1.4B
 
Common Stock $31K $31K $31K $31K $31K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $593.2M $724.9M $939.3M $1.1B $1.2B
 
Total Liabilities and Equity $2B $2.1B $2.3B $2.4B $2.6B
Cash and Short Terms $327.7M $246.7M $214.6M $345.6M $203.9M
Total Debt $1.1B $1.1B $983.4M $978M $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $52.2M $122M $220.7M $158.6M $140.2M
Depreciation & Amoritzation $15.6M $14M $13.4M $12.2M $14.9M
Stock-Based Compensation $10M $12.2M $8.5M $7.3M $7.4M
Change in Accounts Receivable $6.8M -$5.3M -$10.2M $279K -$19.8M
Change in Inventories $154.9M -$147.5M -$231.4M -$14.7M -$282.1M
Cash From Operations $289.1M $31.7M $81.1M $178.1M -$137.5M
 
Capital Expenditures $10.6M $14.6M $15M $20.3M $22.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$10.2M -$14.2M -$14.7M -$29.7M -$30M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $390M -- $195M -- $530M
Long-Term Debt Repaid -$441.2M -$82.5M -$268.9M -$9M -$482.2M
Repurchase of Common Stock -$3.3M -- -$8.2M -- -$12.9M
Other Financing Activities -$2.9M -$3.9M -$6.6M -$5.2M -$11M
Cash From Financing -$59.2M -$85.9M -$88.7M -$13.9M $23.9M
 
Beginning Cash (CF) $122.8M $342.5M $274.1M $251.8M $386.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $219.7M -$68.4M -$22.3M $134.5M -$143.7M
Ending Cash (CF) $342.5M $274.1M $251.8M $386.3M $242.6M
 
Levered Free Cash Flow $278.5M $17M $66M $157.7M -$159.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $23.7M $48.4M $86.8M $55.8M $52.1M
Depreciation & Amoritzation $4.8M $3.5M $4.3M $3.8M $5.2M
Stock-Based Compensation $5.2M $2.9M $2M $2M $1.9M
Change in Accounts Receivable -$2M -$2.2M -$10.8M -$12.4M $818K
Change in Inventories $161.5M -$92.6M $120M -$13.5M $130.6M
Cash From Operations $230.1M -$46.9M $245.6M $82.2M $185.4M
 
Capital Expenditures $3.1M $4.3M $3.9M $6.2M $5.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.9M -$4.2M -$3.8M -$7.9M -$6.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $45M -- $115M -- $85M
Long-Term Debt Repaid -$95M -$57.3M -$181.2M -$4M -$130M
Repurchase of Common Stock -- -- -$5.6M -- --
Other Financing Activities -$117K -$474K -- -- -$129K
Cash From Financing -$50.1M -$57.8M -$71.8M -$3.8M -$45.1M
 
Beginning Cash (CF) $165.4M $383M $81.8M $315.7M $108.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $177.2M -$108.9M $170M $70.6M $134.2M
Ending Cash (CF) $342.5M $274.1M $251.8M $386.3M $242.6M
 
Levered Free Cash Flow $227M -$51.2M $241.7M $76M $179.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $52.2M $122M $220.7M $158.6M $140.2M
Depreciation & Amoritzation $15.6M $14M $13.4M $12.2M $14.9M
Stock-Based Compensation $10M $12.2M $8.5M $7.3M $7.4M
Change in Accounts Receivable $6.8M -$5.3M -$10.2M $279K -$19.8M
Change in Inventories $154.9M -$147.5M -$231.4M -$14.7M -$282.1M
Cash From Operations $289.1M $31.7M $81.1M $178.1M -$137.5M
 
Capital Expenditures $10.6M $14.6M $15M $20.3M $22.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$10.2M -$14.2M -$14.7M -$29.7M -$30M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $390M -- -- -- $530M
Long-Term Debt Repaid -$441.2M -- -- -$9M -$482.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2.9M -$3.9M -$6.6M -$5.2M -$11M
Cash From Financing -$59.2M -$85.9M -$88.7M -$13.9M $23.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $219.7M -$68.4M -$22.3M $134.5M -$143.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $278.5M $17M $66M $157.7M -$159.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $122M $220.7M $158.6M $140.2M --
Depreciation & Amoritzation $14M $13.4M $12.2M $14.9M --
Stock-Based Compensation $12.2M $8.5M $7.3M $7.4M --
Change in Accounts Receivable -$5.3M -$10.2M $279K -$19.8M --
Change in Inventories -$147.5M -$231.4M -$14.7M -$282.1M --
Cash From Operations $31.7M $81.1M $178.1M -$137.5M --
 
Capital Expenditures $14.6M $15M $20.3M $22.4M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$14.2M -$14.7M -$29.7M -$30M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $195M -- $530M --
Long-Term Debt Repaid -$82.5M -$268.9M -$9M -$482.2M --
Repurchase of Common Stock -- -$8.2M -- -$12.9M --
Other Financing Activities -$3.9M -$6.6M -$5.2M -$11M --
Cash From Financing -$85.9M -$88.7M -$13.9M $23.9M --
 
Beginning Cash (CF) $1.4B $740.1M $1B $798.4M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$68.4M -$22.3M $134.5M -$143.7M --
Ending Cash (CF) $1.3B $717.8M $1.1B $654.8M --
 
Levered Free Cash Flow $17M $66M $157.7M -$159.9M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.2% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock